PE20020755A1 - Procedimiento para la preparacion de un anticolinergico - Google Patents

Procedimiento para la preparacion de un anticolinergico

Info

Publication number
PE20020755A1
PE20020755A1 PE2001001285A PE2001001285A PE20020755A1 PE 20020755 A1 PE20020755 A1 PE 20020755A1 PE 2001001285 A PE2001001285 A PE 2001001285A PE 2001001285 A PE2001001285 A PE 2001001285A PE 20020755 A1 PE20020755 A1 PE 20020755A1
Authority
PE
Peru
Prior art keywords
ester
thenyl
glycolic acid
bromide
procedure
Prior art date
Application number
PE2001001285A
Other languages
English (en)
Spanish (es)
Inventor
Rolf Banholzer
Manfred Graulich
Andreas Mathes
Peter Specht
Wolfgang Broeder
Helmut Meissner
Sven Luettke
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7668836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20020755(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PE20020755A1 publication Critical patent/PE20020755A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2001001285A 2000-12-22 2001-12-20 Procedimiento para la preparacion de un anticolinergico PE20020755A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10064816A DE10064816A1 (de) 2000-12-22 2000-12-22 Verfahren zur Herstellung eines Anticholinergikums

Publications (1)

Publication Number Publication Date
PE20020755A1 true PE20020755A1 (es) 2002-09-24

Family

ID=7668836

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001285A PE20020755A1 (es) 2000-12-22 2001-12-20 Procedimiento para la preparacion de un anticolinergico

Country Status (41)

Country Link
US (1) US6486321B2 (cs)
EP (2) EP1426373B1 (cs)
JP (1) JP4198991B2 (cs)
KR (1) KR100853109B1 (cs)
CN (2) CN1244581C (cs)
AR (1) AR033599A1 (cs)
AT (2) ATE337314T1 (cs)
AU (1) AU2002229650B2 (cs)
BG (1) BG66373B1 (cs)
BR (1) BRPI0116444B8 (cs)
CA (1) CA2433518C (cs)
CY (1) CY1105210T1 (cs)
CZ (1) CZ294958B6 (cs)
DE (3) DE10064816A1 (cs)
DK (2) DK1345936T3 (cs)
EA (1) EA005533B1 (cs)
EC (1) ECSP034652A (cs)
EE (1) EE04495B1 (cs)
EG (1) EG23914A (cs)
ES (2) ES2271722T3 (cs)
HR (1) HRP20030502B1 (cs)
HU (1) HU230320B1 (cs)
IL (2) IL156351A0 (cs)
ME (1) MEP40608A (cs)
MX (1) MXPA03005426A (cs)
MY (1) MY129525A (cs)
NO (1) NO327739B1 (cs)
NZ (1) NZ527066A (cs)
PE (1) PE20020755A1 (cs)
PL (1) PL202478B1 (cs)
PT (2) PT1426373E (cs)
RS (1) RS50271B (cs)
SA (1) SA01220589B1 (cs)
SI (1) SI1345936T1 (cs)
SK (1) SK287318B6 (cs)
TR (1) TR200401127T4 (cs)
TW (1) TWI234564B (cs)
UA (1) UA74409C2 (cs)
UY (1) UY27079A1 (cs)
WO (1) WO2002051840A1 (cs)
ZA (1) ZA200304707B (cs)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0107304A (pt) * 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Pó para inalação contendo tiotrópio
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US6852728B2 (en) 2000-10-14 2005-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
US20020137764A1 (en) 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
WO2003000265A1 (de) * 2001-06-22 2003-01-03 Boehringer Ingelheim Pharma Gmbh & Co.Kg Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7405224B2 (en) * 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7311894B2 (en) * 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
EP1494648B1 (en) * 2002-04-04 2006-09-20 Boehringer Ingelheim Pharma GmbH & Co.KG Powder formulations suitable for inhalation
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2083007B1 (de) * 2003-11-03 2013-04-24 Boehringer Ingelheim International Gmbh Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
EA012326B1 (ru) 2003-11-03 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх Способ получения солей тиотропия, соли тиотропия, а также содержащие их лекарственные композиции
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
PT1881980E (pt) 2005-05-02 2012-12-06 Boehringer Ingelheim Int Novas formas cristalinas de brometo de tiotrópio
KR20080007656A (ko) * 2005-05-02 2008-01-22 베링거 인겔하임 인터내셔날 게엠베하 티오트로피움 브로마이드의 신규한 결정질 형태
NZ583872A (en) * 2005-06-15 2011-10-28 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
CN1316245C (zh) * 2005-07-28 2007-05-16 山东齐都药业有限公司 托烷司琼合成中残留中间体托品醇的检测方法
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
DE102005059602A1 (de) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
CN102731494A (zh) * 2005-12-19 2012-10-17 西科尔公司 噻托溴铵的新形式及其制备方法
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
CA2620142A1 (en) * 2005-12-19 2007-07-05 Sicor Inc. Pure and stable tiotropium bromide
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
CN100410254C (zh) * 2006-03-07 2008-08-13 南昌弘益科技有限公司 噻托溴铵无水物制备方法
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
EP1882691A1 (en) * 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Quinuclidine derivatives as M3 antagonists
EP1950196A1 (de) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Ammoniumhexafluorophosphaten
EP2036898A2 (de) * 2007-09-13 2009-03-18 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von 1,3-Dioxolan-2Onen sowie von Carbonsäureestern durch Transacylierung unter Basischen Reaktionsbedingungen
WO2009087419A1 (en) * 2008-01-10 2009-07-16 Generics [Uk] Limited Novel process for the preparation of scopine esters
WO2011015884A1 (en) * 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
WO2011015882A2 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Novel anhydrate
CN101768158B (zh) * 2010-01-04 2013-05-29 南昌弘益科技有限公司 噻托溴铵无水物及其制备方法
CN101863885B (zh) * 2010-06-03 2012-05-30 南京金丹呈医药技术有限公司 一种噻托溴铵的制备方法
TR201007108A2 (tr) * 2010-08-25 2012-03-21 B�Lg�� Mahmut Yeni tiotropyum bromür kristali ve üretim yöntemi.@
ITRM20110508A1 (it) 2011-09-27 2013-03-28 Lusochimica Spa Processo per la preparazione degli esteri della scopina.
PT2607351T (pt) * 2011-12-22 2017-05-26 Cerbios-Pharma S A Processo contínuo para a alquilação de aminas terciárias cíclicas
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
CZ305012B6 (cs) * 2012-03-30 2015-03-25 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu
RU2015146871A (ru) 2013-04-01 2017-05-10 Пулматрикс, Инк. Сухие порошки с тиотропием
WO2018055642A1 (en) * 2016-09-23 2018-03-29 Gbr Laboratories Pvt. Ltd. A process for preparing tiotropium bromide and intermediates thereof
WO2019129801A1 (en) 2017-12-28 2019-07-04 Linnea S.A. Process for the purification of methyl-2,2-dithienylglycolate
CN113264929B (zh) * 2021-05-02 2023-10-10 润生药业有限公司 一种噻托溴铵的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
BR0116444A (pt) 2003-12-23
TWI234564B (en) 2005-06-21
HUP0301457A2 (hu) 2003-10-28
AR033599A1 (es) 2003-12-26
EG23914A (en) 2007-12-30
TR200401127T4 (tr) 2004-07-21
DE50110835D1 (de) 2006-10-05
ES2221658T3 (es) 2005-01-01
CY1105210T1 (el) 2010-03-03
RS50271B (sr) 2009-07-15
PL361837A1 (en) 2004-10-04
MEP40608A (en) 2011-02-10
AU2002229650B2 (en) 2006-12-21
EA200300666A1 (ru) 2003-12-25
JP4198991B2 (ja) 2008-12-17
MXPA03005426A (es) 2005-04-20
IL156351A (en) 2011-09-27
CZ20031685A3 (cs) 2003-10-15
EE04495B1 (et) 2005-06-15
EP1426373B1 (de) 2006-08-23
NO20032827L (no) 2003-06-20
SK287318B6 (sk) 2010-07-07
CN1481383A (zh) 2004-03-10
SI1345936T1 (sl) 2004-08-31
HK1096683A1 (zh) 2007-06-08
PT1426373E (pt) 2006-11-30
CZ294958B6 (cs) 2005-04-13
NZ527066A (en) 2004-12-24
KR100853109B1 (ko) 2008-08-21
CN1840529A (zh) 2006-10-04
DK1426373T3 (da) 2006-12-18
UA74409C2 (uk) 2005-12-15
ATE337314T1 (de) 2006-09-15
US20020133010A1 (en) 2002-09-19
BG107910A (bg) 2004-02-27
EP1345936A1 (de) 2003-09-24
UY27079A1 (es) 2002-07-31
MY129525A (en) 2007-04-30
NO20032827D0 (no) 2003-06-20
PL202478B1 (pl) 2009-06-30
EE200300309A (et) 2003-10-15
JP2004525099A (ja) 2004-08-19
HK1060570A1 (en) 2004-08-13
DE10064816A1 (de) 2002-06-27
SK9352003A3 (en) 2003-10-07
HRP20030502A2 (en) 2005-04-30
ECSP034652A (es) 2003-07-25
HRP20030502B1 (en) 2011-09-30
PT1345936E (pt) 2004-09-30
BG66373B1 (bg) 2013-10-31
EA005533B1 (ru) 2005-04-28
SA01220589B1 (ar) 2006-10-31
DE50102299D1 (de) 2004-06-17
ATE266661T1 (de) 2004-05-15
HUP0301457A3 (en) 2006-05-29
BRPI0116444B1 (pt) 2015-09-01
CA2433518A1 (en) 2002-07-04
ES2271722T3 (es) 2007-04-16
HU230320B1 (hu) 2016-01-28
CN1244581C (zh) 2006-03-08
EP1426373A1 (de) 2004-06-09
BRPI0116444B8 (pt) 2021-05-25
WO2002051840A1 (de) 2002-07-04
ZA200304707B (en) 2004-04-20
CN100393719C (zh) 2008-06-11
KR20030062439A (ko) 2003-07-25
NO327739B1 (no) 2009-09-14
US6486321B2 (en) 2002-11-26
IL156351A0 (en) 2004-01-04
DK1345936T3 (da) 2004-07-19
EP1345936B1 (de) 2004-05-12
YU50903A (sh) 2006-05-25
CA2433518C (en) 2007-03-20

Similar Documents

Publication Publication Date Title
PE20020755A1 (es) Procedimiento para la preparacion de un anticolinergico
ES2229538T7 (es) Derivados de pleuromutilina como agentes antimicrobianos.
GT200100141A (es) Esteres oxigenados de acidos 4-yodo fenilamino benzhidroxamicos.
ES2150941T3 (es) Aminas biciclicas-heterociclicas eficaces farmaceuticamente.
PE20030964A1 (es) Anticolinergicos y procedimiento para su preparacion
AR083071A1 (es) Uso de analogos de nucleosidos y nucleotidos para tratar infecciones virales por paramixovirus y/o ortomixovirus, compuestos relacionados y composiciones farmaceuticas que los contienen
ES2123654T3 (es) Carbapenems que contienen un grupo fenilo substituido con carboxi, procesos para su preparacion, productos intermedios y uso como antibioticos.
PE20120997A1 (es) Compuestos policiclicos como antagonistas del receptor de acido lisofosfatidico
PT949260E (pt) Sal de adicao de acido de composto de piperidina opticamente activo e processo para a preparacao do mesmo
PE20091583A1 (es) Solucion para infusion de dihidropteridinonas estabilizada para el almacenamiento
AU2002361218A1 (en) Method for producing scopine esters
CR8756A (es) Derivados de acido carboxilico bencimidazolona
TR20481A (tr) Herbisid olarak mueessir halojene 4-piridil-(2)-oksi/-a-fenoksi-propionik asid doymamis esterleri
ES2242022T3 (es) Procedimiento de sintesis tecnica para la preparacion de tropenol.
CO5611150A2 (es) Formulacion en aerosol de una sal de tiotropio de administracion directa para inhalacion
ECSP003680A (es) Proceso para derivados del acido fenilacetico
IT7947811A0 (it) Zilico sostituito racemico ovvero esteri di acido acetico sostituito otticamente attivo dotati di pro otticamente attivo e di alcool benprieta&#39; insetticide procedimento per la loro produzione e composizioni insetticide che li contengono
IT1165252B (it) Procedimento di purificazione dell&#39;acido ursodesossicolico attraverso nuovi derivati
DK360584A (da) Triazol-pyrimidinderivater og fremgangsmaade til fremstilling deraf samt disses terapeutiske anvendelse som cardiotoniske midler
PE20030092A1 (es) Formulacion de una solucion de inhalacion con una sal de tiotropio
BR0110255A (pt) Cromenilmetil pirimidinadiaminas como agentes antibacterianos
SE8305917L (sv) Mellanprodukter for anvendning vid framstellning av hexahydro-gamma-karbolinforeningar
NO156566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridiner.
ES2202090T3 (es) Enantiomeros de mercaptolactonas y procedimiento para su sintesis.
MEP47408A (en) Hfa-suspension formulations containing an anticholinergic

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed